![image](https://chiefaiexpert.com/upload/photos/2022/04/W7wZteYNXi3kSRdrsqYo_14_0e522b501e1f1482d0bcd47808e7ead6_image_small.jpg)
Nulojix
The product is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Structurally, the product is a glycosylated fusion protein with a MALDI-MS molecular weight of 92,300 Da and it is a homodimer of two homologous polypeptide chains of 357 amino acids each. It is produced through recombinant DNA technology in mammalian CHO cells. The drug has activity as a selective co-stimulation modulator with inhibitory activity on T lymphocytes. Nulojix https://www.creativebiomart.ne....t/therapeutic-protei